TWA
IRWD icon

TCI Wealth Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

TCI Wealth Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-864
Closed -$9.09K – 1194
2023
Q1 		$9.09K Hold
864
– – ﹤0.01% 1147
2022
Q4 		$10.7K Buy
864
+856
+10,700% +$9.71K ﹤0.01% 1031
2022
Q3 		$0 Sell
8
-732
-99% -$8.3K ﹤0.01% 2417
2022
Q2 		$9K Hold
740
– – ﹤0.01% 1083
2022
Q1 		$9K Buy
+740
New +$8.48K ﹤0.01% 1164
2021
Q4 		– Sell
-452
Closed -$6K – 2407
2021
Q3 		$6K Buy
452
+234
+107% +$3.02K ﹤0.01% 1469
2021
Q2 		$3K Buy
218
+38
+21% +$435 ﹤0.01% 1773
2021
Q1 		$2K Buy
+180
New +$1.9K ﹤0.01% 1778

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

TCI Wealth Advisors's IRWD Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2023, closing a stake of 864 shares — an estimated $9.09K sold.

TCI Wealth Advisors first reported a position in IRWD in Q1 2021 and held it in 8 quarters. The position peaked at $10.7K in Q4 2022. 252 funds tracked by Wall St. Rank hold IRWD as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Ironwood Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 864 Ironwood Pharmaceuticals shares in Q2 2023, an estimated $9.09K.
  • TCI Wealth Advisors first reported a position in Ironwood Pharmaceuticals in Q1 2021 and held it in 8 quarters.
  • TCI Wealth Advisors's Ironwood Pharmaceuticals position peaked at $10.7K in Q4 2022.
  • 252 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.